94339-31-8

Upstream product

• 64793-97-1 3-(3,5-dibenzyloxyphenyl)-propanic acid 
• 24131-31-5 3,5-dibenzyloxybenzyl alcohol 
• 99-10-5 3,5-Dihydroxybenzoic acid 
• 58605-10-0 methyl 3,5-bis(benzyloxy)benzoate 
• 2150-44-9 1-carbomethoxy-3,5-dihydroxybenzene 
• 14615-72-6 3,5-dibenzyloxybenzaldehyde 
• 186136-24-3 (Z)-3-(3,5-Bis-benzyloxy-phenyl)-acrylic acid ethyl ester 

Downstream Products

• 93359-28-5 3-(3,5-dihydroxyphenyl)-1-propanol 
• 479547-25-6 1,3-Bis-benzyloxy-5-(3-bromo-propyl)-benzene 
• 1027392-71-7 C₅₅H₅₅BrO₆ 
• 479547-28-9 3-{3,5-bis-[3-(3,5-bis-benzyloxy-phenyl)-propoxy]-phenyl}-propan-1-ol 
• 94339-33-0 3-(3,5-dibenzyloxyphenyl)-1-methoxypropane 
• 94339-23-8 3-(3,5-dihydroxyphenyl)-1-methoxypropane 
• 94339-32-9 3-(3,5-dibenzyloxyphenyl)-1-methanesulphonyloxypropane 

Relevant academic research and scientific papers

A new convergent approach to dendritic macromolecules

The novel convergent growth approach to dendritic macromolecules is described. Polyether dendritic sectors [G-na]-OH from the first to the fourth generations, respectively, were prepared by this approach from readily available starting material.

Dibenzo[bd]pyran derivatives, process for the preparation thereof and pharmaceutical compositions containing same

2,6-di-O-methyl-beta-cyclodextrin complexes of compounds of the formula (1a) STR1 wherein R2' stands for C1 to C12 alkyl or a group of the formula STR2 in which R11 is C1 to C4 alkyl; R12 is hydrogen or C1 to C4 alkyl; n is 0 or 1; p is 1 to 4; r is 1 to 4; and R3' and R4' are each C1 to C4 alkyl, or pharmaceutically salts thereof are disclosed, having analgesic activity.

Cannabinoids with an ether side chain. Synthesis. Solubilization and analgesic properties

A series of the title compounds was synthesized of which the 5-methoxy- and 5-ethoxy-2-pentyl derivatives proved to be analgesics with a potency exceeding that of morphine when solubilized with 2,6-di-O-methyl-β-cyclodextrin.